Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interleukin‐6 Blocking Agents for Treating COVID‐19: a Living Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439621/all/Interleukin‐6_blocking_agents_for_treating_COVID‐19:_a_living_systematic_review.
Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439621/all/Interleukin‐6_blocking_agents_for_treating_COVID‐19:_a_living_systematic_review. Accessed March 20, 2025.
Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439621/all/Interleukin‐6_blocking_agents_for_treating_COVID‐19:_a_living_systematic_review
Interleukin‐6 Blocking Agents for Treating COVID‐19: a Living Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439621/all/Interleukin‐6_blocking_agents_for_treating_COVID‐19:_a_living_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review
ID - 439621
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439621/all/Interleukin‐6_blocking_agents_for_treating_COVID‐19:_a_living_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -